Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

1.88CAD
30 Jun 2016
Change (% chg)

$0.99 (+111.24%)
Prev Close
$0.89
Open
$1.79
Day's High
$1.93
Day's Low
$1.79
Volume
412,433
Avg. Vol
22,612
52-wk High
$3.87
52-wk Low
$0.89

Cruz, Tony 

Dr. Tony Cruz is Chairman of the Board, Chief Executive Officer of Transition Therapeutics Inc. Dr. Cruz is one of the founders of Transition Therapeutics and has held the position of Chief Executive Officer of Transition Therapeutics since its inception in July 1998. Dr. Cruz was a Co-Founder, Vice-President and Director at Angiotech Pharmaceuticals Inc. Dr. Cruz has been a Senior Scientist at Mount Sinai Hospital since 1995 and was the CEO and President of the Canadian Arthritis Network until 2001. He has also served as a consultant for biotechnology companies and investment firms.

Basic Compensation

Total Annual Compensation, CAD 423,300
Restricted Stock Awards, CAD --
Long-Term Incentive Plans, CAD --
All Other, CAD 1,576
Fiscal Year Total, CAD 424,876

Options Compensation

  Quantity Market Value
Exercisable 132,871 599,213.00
Unexercisable 333,796 342,120.00
Exercised -- --
Name Fiscal Year Total

Tony Cruz

424,876

Carl Damiani

199,228

Nicole Rusaw

316,054

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of  29 Jun 2013